Published 2022 | Version v1
Publication Metadata-only

Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia

Bassetti, Matteo
Labate, Laura
Melchio, Monica
Robba, Chiara
Battaglini, Denise
Ball, Lorenzo
Pelosi, Paolo
Giacobbe, Daniele Roberto
Others:
Bassetti, Matteo
Labate, Laura
Melchio, Monica
Robba, Chiara
Battaglini, Denise
Ball, Lorenzo
Pelosi, Paolo
Giacobbe, Daniele Roberto

Description

Currently, several antibiotics are active against methicillin-resistant Staphylococcus aureus (MRSA) and can be used for the treatment of pneumonia. They show great variability in terms of antibiotic class, indication, pharmacodynamic/pharmacokinetic properties, type of available formulations, spectrum of activity against bacteria other than MRSA, and toxicity profile.

Additional details

Identifiers Origin repository
Created:
February 14, 2024
Modified:
February 14, 2024